128 related articles for article (PubMed ID: 30217355)
1. Change in hazard rates of recurrence over time following diagnosis of endometrial cancer: An age stratified multicentre study from the FRANCOGYN group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Bricou A; Huchon C; Daraï E; Ballester M;
Eur J Surg Oncol; 2018 Dec; 44(12):1914-1920. PubMed ID: 30217355
[TBL] [Abstract][Full Text] [Related]
2. Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.
Bendifallah S; Ouldamer L; Lavoue V; Canlorbe G; Raimond E; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
Gynecol Oncol; 2017 Jan; 144(1):107-112. PubMed ID: 27789083
[TBL] [Abstract][Full Text] [Related]
3. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
[TBL] [Abstract][Full Text] [Related]
4. Pattern of recurrence in patients with endometrial cancer: A retrospective study.
Vizza E; Cutillo G; Bruno V; Sperduti I; Mancini E; Baiocco E; Chiofalo B; Cicchillitti L; Certelli C; Zampa A; Piccione E; Corrado G
Eur J Surg Oncol; 2020 Sep; 46(9):1697-1702. PubMed ID: 32204935
[TBL] [Abstract][Full Text] [Related]
5. Incidence, patterns and prognosis of first distant recurrence after surgically treated early stage endometrial cancer: Results from the multicentre FRANCOGYN study group.
Ouldamer L; Bendifallah S; Body G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Bricou A; Lavoué V; Lévêque J; Daraï E; Ballester M;
Eur J Surg Oncol; 2019 Apr; 45(4):672-678. PubMed ID: 30722948
[TBL] [Abstract][Full Text] [Related]
6. A Proposal for a Classification for Recurrent Endometrial Cancer: Analysis of a French Multicenter Database From the FRANCOGYN Study Group.
Bricou A; Bendifallah S; Daix-Moreux M; Ouldamer L; Lavoue V; Benbara A; Huchon C; Canlorbe G; Raimond E; Coutant C; Graesslin O; Collinet P; Carcopino X; Touboul C; Daraï E; Carbillon L; Ballester M;
Int J Gynecol Cancer; 2018 Sep; 28(7):1278-1284. PubMed ID: 29994907
[TBL] [Abstract][Full Text] [Related]
7. Use of Aggressive Surveillance for Locoregional Endometrial Cancer After Local Therapy.
Yalamanchi P; Shabason JE; Zhang X; Ko EM; Lin LL
Int J Gynecol Cancer; 2018 Sep; 28(7):1264-1270. PubMed ID: 30036223
[TBL] [Abstract][Full Text] [Related]
8. The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study.
Buda A; Restaino S; Di Martino G; De Ponti E; Monterossi G; Dinoi G; Magni S; Quagliozzi L; Dell'Orto F; Ciccarone F; Lamanna M; Scambia G; Landoni F; Fanfani F
Eur J Surg Oncol; 2018 Oct; 44(10):1562-1567. PubMed ID: 30077521
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Recurrence, Long-term Survival and Toxicity Analysis of Endometrial Adenocarcinoma Patients Reclassified Under the Recent ESMO-ESGO-ESTRO Stratification: Seven-Year Results From a Single Institution.
Kumar UP; Yathiraj PH; Sharan KT; Kamath A; Singh A; Reddy SA; Alurkar P; Fernandes DJ; Mamidipudi VS
Int J Gynecol Cancer; 2018 Jun; 28(5):854-860. PubMed ID: 29683879
[TBL] [Abstract][Full Text] [Related]
10. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
11. Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter Study.
Canlorbe G; Bendifallah S; Raimond E; Graesslin O; Hudry D; Coutant C; Touboul C; Bleu G; Collinet P; Darai E; Ballester M
Ann Surg Oncol; 2015 Aug; 22(8):2714-21. PubMed ID: 25503347
[TBL] [Abstract][Full Text] [Related]
12. Honing the classification of high-risk endometrial cancer with inclusion of lymphovascular space invasion.
Bendifallah S; Perrin M; Ouldamer L; Lavoué V; Canlorbe G; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
Surg Oncol; 2017 Mar; 26(1):1-7. PubMed ID: 28317578
[TBL] [Abstract][Full Text] [Related]
13. Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model.
Ren K; Wang W; Sun S; Hou X; Hu K; Zhang F
Cancer Med; 2022 Jan; 11(1):257-267. PubMed ID: 34779587
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.
Topfedaisi Ozkan N; Meydanlı MM; Sarı ME; Demirkiran F; Kahramanoglu I; Bese T; Arvas M; Şahin H; Haberal A; Celik H; Coban G; Oge T; Yalcin OT; Akbayır Ö; Erdem B; Numanoğlu C; Özgül N; Boyraz G; Salman MC; Yüce K; Dede M; Yenen MC; Taşkın S; Altın D; Ortaç UF; Aydın Ayık H; Şimşek T; Güngör T; Güngördük K; Sancı M; Ayhan A
J Gynecol Oncol; 2017 Sep; 28(5):e65. PubMed ID: 28657226
[TBL] [Abstract][Full Text] [Related]
15. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
16. A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre study.
Bendifallah S; Canlorbe G; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Collinet P; Bleu G; Daraï E; Ballester M
Ann Surg Oncol; 2014 Dec; 21(13):4239-45. PubMed ID: 24969441
[TBL] [Abstract][Full Text] [Related]
17. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
[TBL] [Abstract][Full Text] [Related]
18. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
Ben Arie A; Lavie O; Gdalevich M; Voldarsky M; Barak F; Schneider D; Levy T; Anteby E; Gemer O
Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
[TBL] [Abstract][Full Text] [Related]
19. Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival.
Obermair A; Manolitsas TP; Leung Y; Hammond IG; McCartney AJ
Gynecol Oncol; 2004 Mar; 92(3):789-93. PubMed ID: 14984942
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma.
Yoon MS; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Lee KK; Kim M; Jeong JU; Chang SK; Park W
Cancer Res Treat; 2016 Jul; 48(3):1074-83. PubMed ID: 26511800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]